1-4 of 4
Liang Huang, MD PhD
Close
Sort by
Journal Articles

SHP-1 As a Negative Regulator of FLT3 Associated Aberrant Signaling and a New Potential Target to FLT3-ITD Mutation

Tongjuan Li, MD PhD, Dan Li, Lei Zhao, MD, Jue Wang, MD PhD, Zhen Shang, MD PhD, Yicheng Zhang, MD PhD, Liang Huang, MD PhD, Jianfeng Zhou, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4051.
https://doi.org/10.1182/blood-2018-99-115793
Published: 2018
Journal Articles

Heterogeneous Responses Among Ph + -B-ALLs to Imatinib with NRAS Mutant Being One Mechanism of Complete Resistance

Xiaoyu An, Jinping Liu, Na Wang, MD PhD, Di Wang, MD PhD, Liang Huang, MD PhD, Jie Cai, PhD, Demin Zhou, PhD, Henry Li, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5801.
https://doi.org/10.1182/blood-2018-99-115516
Published: 2018
Journal Articles

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells Following Autologous HSCT in Patients with B-NHL

Yang Cao, Na Wang, MD PhD, Gaoxiang Wang, MD PhD, Yi Xiao, MD PhD, Liang Huang, MD PhD, Chunrui Li, MD PhD, Min Xiao, MD PhD, Tongcun Zhang, PhD, Yicheng Zhang, MD PhD, Jianfeng Zhou, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2054.
https://doi.org/10.1182/blood-2018-99-113827
Published: 2018
Journal Articles

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for Adult Patients with Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia

Liang Huang, MD PhD, Na Wang, MD PhD, Chunrui Li, MD PhD, Yang Cao, MD PhD, Yi Xiao, MD PhD, Min Xiao, MD PhD, Yicheng Zhang, MD PhD, Tongcun Zhang, PhD, Jianfeng Zhou, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 846.
https://doi.org/10.1182/blood.V130.Suppl_1.846.846
Published: 2017